CBS Evening News | Eli Lilly seeks FDA approval for weight loss drug

Pharmaceutical giant Eli Lilly is requesting fast-track approval from the Food and Drug Administration for its Type 2 diabetes medication tirzepatide to be sold as a weight loss drug. The company said that new studies have shown promising results. Nikki Battiste has more. Air Date: Apr 27, 2023